The Structure of the Adenosine Receptors: Implications for Drug Discovery

J. Robert Lane, Veli-Pekka Jaakola, Adriaan P IJzerman

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

10 Citations (Scopus)

Abstract

Extracellular adenosine mediates most of its physiological effects via an interaction with four G protein-coupled receptors (GPCRs), the adenosine receptors (ARs). These ARs are important pharmacological targets in the treatment of a wide variety of diseases from central nervous system disorders to ischemic injury. As for other GPCRs, drug development for the ARs has been hampered by the lack of structural data for this class of membrane proteins. However, in the past 3 years, this situation has changed with the elucidation of structures for the turkey β1-adrenoceptor, the human β2-adrenoceptor, squid rhodopsin, the activated form of bovine (rhod)opsin, the human adenosine A2A receptor, and most recently the CXCR4 chemokine receptor. In this review, the structural features of the human adenosine A2A receptor will be discussed with a particular focus on the ligand binding site. Further, the implications of this structural information for AR ligand selectivity, drug screening, homology modeling, and virtual ligand screening will be discussed.

Original languageEnglish
Title of host publicationAdvances in Pharmacology
Subtitle of host publicationPharmacology of Purine and Pyrimidine Receptors
EditorsKenneth A Jacobson, Joel Linden
Place of PublicationAmsterdam The Netherlands
PublisherElsevier
Chapter1
Pages1-40
Number of pages40
Volume61
ISBN (Electronic)9780123855268
DOIs
Publication statusPublished - 2011

Keywords

  • Adenosine receptors
  • Crystal structure
  • G protein-coupled receptors
  • Ligand selectivity
  • Molecular modeling
  • Virtual ligand screening

Cite this